Anthony Martinelli is founder and Editor-in-Chief of The Marijuana Herald. Anthony previously served as Editor-in-Chief of TheJointBlog.com (a cannabis news site he founded in 2011 and sold in 2019), and he has worked as a campaign manager and communications director for multiple political campaigns and elected officials. Anthony can be reached at Info@TheMarijuanaHerald.com.
Anthony Martinelli
Author's posts
Maine: Bipartisan and Bicameral Coalition of Lawmakers File Bill to Decriminalize Psilocybin
A bipartisan and bicameral group of nine Maine lawmakers introduced legislation that would decriminalize the possession of personal-use amounts of psilocybin. Filed today, House Bill 1034 has been referred to the Committee on Criminal Justice and Public Safety for consideration. If enacted, the bill would remove criminal penalties for adults 21 and older who possess …
Iowa House Committee Overwhelmingly Approves Bill to Expand Medical Marijuana Program by Allowing Dried Flower
A bill that would allow qualified patients to purchase and possess dried marijuana flower for vaporization has been passed by the House Health and Human Services Committee in a decisive 19 to 1 vote. House File 105, now renumbered as House File 950, seeks to amend Iowa’s medical marijuana program by permitting the use of …
Maryland House Committee Approves Bill to Legalize Personal Cannabis Concentrate Production and Expand Resentencing Options
The Maryland House Judiciary Committee has approved a measure that would legalize the personal production of solventless cannabis concentrates while enabling certain individuals to seek reduced sentences for specific marijuana-related offenses. “A person who is at least 21 years old may manufacture a personal use amount of cannabis products or concentrated cannabis for personal use …
New Mexico Senate Passes Bill to Legalize Medical Psilocybin
New Mexico’s full Senate has given approval to legislation that would legalize medical psilocybin. The New Mexico Senate voted 33 to 4 today to approve Senate Bill 219, the Medical Psilocybin Act, moving the measure to the House for consideration. The legislation had previously cleared the Senate Finance Committee on Monday, following earlier approvals by …
Minnesota Senate Committee Advances Bill to Expand Marijuana Expungement and Resentencing Eligibility
The Minnesota Senate Judiciary and Public Safety Committee has unanimously approved Minnesota Senate Bill 204, a measure that would expand eligibility for expungements and resentencing for individuals with marijuana-related convictions. The bill, introduced by State Senators Lindsey Port, Clare Oumou Verbeten, and Matt Klein, now moves towards a vote by the full Senate. SF 204 …
Missouri Senate Committee Approves Medical Psilocybin Bill
The Missouri Senate Families, Seniors and Health Committee has approved Senate Bill 90, advancing a proposal that would provide legal access to psilocybin-assisted therapy for certain patients. Filed in December by State Senator Stephen Webber (D), the bill now moves forward for further consideration in the legislature. SB 90 would allow veterans suffering from PTSD, …
Georgia Lawmakers Introduce Bipartisan Bill to Regulate Kratom Sales
A bipartisan group of five Georgia lawmakers has introduced House Bill 757, a measure that would regulate the sale of kratom products in the state. Filed today by Representatives Kelley, Jasperse, Kendrick, Ridley, and Mathis, the bill would require kratom processors to register their products annually with the Department of Agriculture and meet strict compliance …
Study Finds Cannabis Terpenes Effectively Treat Fibromyalgia and Post-Surgical Pain
A new government-funded study published in Pharmacology Reports has found that certain terpenes found in cannabis may provide effective relief for fibromyalgia and post-surgical pain. The research, conducted by the University of Arizona Health Sciences and funded by the National Institutes of Health, builds on prior studies demonstrating terpenes’ pain-relieving properties in models of inflammation …
Report: CBD-Infused Products Market Valued at $45 Billion, Expected to Grow to $291 Billion by 2032
According to a new market research report published by Meticulous Research, the CBD-infused products market is expected to reach a value of $291.39 billion by 2032, at a CAGR of 30.6% from 2025 to 2032. The CBD-infused products market “is experiencing robust growth driven primarily by increasing consumer demand for cannabis products, expanding legalization across various jurisdictions, and …
The Fascinating History of CBD and How it was Discovered: From Ancient Times to Modern Science
By California Blendz Understanding the Origins of CBD and its Historical Significance CBD, short for cannabidiol, has gained significant attention in recent years for its potential health benefits. However, the history of CBD can be traced back much further than its modern-day popularity. In this section, we will delve into the discovery and historical significance …
